Vonsetamig

• UNSPSC Description:

  Vonsetamig is a humanised immunoglobulin G4-kappa, anti-TNFRSF17 and CD3E bispecific antibody. Vonsetamig is an antineoplastic[1].

• Target Antigen:

  CD3; TNF Receptor

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Apoptosis;Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/vonsetamig.html

• Purity:

  95.00

• Solubility:

  10 mM in DMSO

• Smiles:

  [Vonsetamig]

• References & Citations:

  [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  -80°C

• Clinical Information:

  No Development Reported

• CAS Number:

  2408319-33-3